Sachetta Eric purchased $67K of SRTS

Sachetta Eric purchased 20,633 shares of Sensus Healthcare, Inc. (SRTS) at an average of $3.23 ($3.18–$3.29) across 2 trades over 2026-08-26 to 2026-08-27.

Original reporting
SEC EDGAR · Sachetta Eric
Published Aug 28, 2026, 6:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 6:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SRTS
Neutral
high confidence
Mentioned
$SRTS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SRTSNeutralLow
01

Why it matters

The director's purchase modestly raises his ownership but is unlikely to move the stock.

02

Market read

Limited relevance; typical for small insider purchases.

03

What to watch

Potential upcoming clinical trial results not disclosed.

Relevance 4/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$SRTSNeutralHigh confidence
Context

Director Eric Sachetta bought 20,633 shares for $66.7K, increasing his stake to 229,943 shares.

Expected impact

Minimal short-term price movement expected.

Evidence & confidence

Purchase size is modest relative to market cap; typical insider buying effect is muted.

Market effects

None

None

None

Counterpoint

Insider buying could be a precursor to upcoming positive news.

Key entities

  • Sensus Healthcare, Inc.

    Biopharma company listed under ticker SRTS.

  • Eric Sachetta

    Director of Sensus Healthcare.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SRTSMed

Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights

Sensus Healthcare, Inc. (SRTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights Commercial Momentum Builds with Broader Physician Engagement and Customer Adoption New Dermatology Group Relationships Support Customer Expansion and Diversification Strategy Incre

$SRTSMed

Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights

Sensus Healthcare, Inc. (SRTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights Commercial Momentum Builds Following CPT Code Implementation Revenue Recognition on Eight Purchased Units Shifted to Q3 Due to Financing Approval Timing CMS Proposed 26% Increase